M. Maat

发表

High functional levels of thrombin‐activatable fibrinolysis inhibitor are associated with an increased risk of first ischemic stroke

F. Leebeek, D. Rijken, D. Dippel, 2005, Journal of thrombosis and haemostasis : JTH.

Seasonal Variation in Fibrinogen in the Rotterdam Study

A. Hofman, D. Grobbee, M. Bots, 1997, Thrombosis and Haemostasis.

The Rationale and Design of the Perindopril Genetic Association Study (PERGENE): A Pharmacogenetic Analysis of Angiotensin-Converting Enzyme Inhibitor Therapy in Patients with Stable Coronary Artery Disease

M. L. Simoons, A. G. Uitterlinden, A. Uitterlinden, 2009, Cardiovascular Drugs and Therapy.

Genetic variation in the C-reactive protein gene and arterial stiffness: The Rotterdam Study

A. Hofman, A. Uitterlinden, R. Reneman, 2008 .

Sensitive markers of inflammation make it possible to study the chronic process: the rise of interest in low levels of C-reactive protein.

C. Kluft, M. D. de Maat, M. de Maat, 2002, Vascular pharmacology.

Fibrin structure and wound healing

P. Koolwijk, M. D. de Maat, N. Laurens, 2006, Journal of thrombosis and haemostasis : JTH.

von Willebrand factor propeptide and the occurrence of a first ischemic stroke

P. D. de Groot, P. Lenting, F. Leebeek, 2010, Journal of thrombosis and haemostasis : JTH.

No Effect of C-Reactive Protein on Early Atherosclerosis Development in Apolipoprotein E*3-Leiden/Human C-Reactive Protein Transgenic Mice

J. Jukema, M. Maas, A. Van der Laarse, 2005, Arteriosclerosis, thrombosis, and vascular biology.

Thrombin activatable fibrinolysis inhibitor is associated with severity and outcome of severe meningococcal infection in children

A. Gils, J. Hazelzet, P. Declerck, 2008, Journal of thrombosis and haemostasis : JTH.

The hypercoagulable state in Cushing's disease is associated with increased levels of procoagulant factors and impaired fibrinolysis, but is not reversible after short-term biochemical remission induced by medical therapy.

J. Romijn, C. de Bruin, R. Netea-Maier, 2012, The Journal of clinical endocrinology and metabolism.

Interindividual and intraindividual variability in plasma fibrinogen, TPA antigen, PAI activity, and CRP in healthy, young volunteers and patients with angina pectoris.

C. Kluft, M. D. de Maat, P. Meijer, 1996, Arteriosclerosis, thrombosis, and vascular biology.

Individualised therapy of angiotensin converting enzyme (ACE) inhibitors in stable coronary artery disease: overview of the primary results of the PERindopril GENEtic association (PERGENE) study

E. Boersma, A. Danser, J. Brugts, 2011, Netherlands Heart Journal.

The role of thrombin activatable fibrinolysis inhibitor in arterial thrombosis at a young age: the ATTAC study 1

J. Deckers, A. Gils, P. Declerck, 2009, Journal of thrombosis and haemostasis : JTH.

Overexpression of Fibrinogen in ApoE*3-Leiden Transgenic Mice Does not Influence the Progression of Diet-Induced Atherosclerosis

J. Verheijen, F. Rezaee, M. D. de Maat, 2002, Thrombosis and Haemostasis.

Calcification and C-reactive protein in atherosclerosis : effects of calcium blocking and cholesterol lowering therapy

J. Jukema, L. Havekes, A. Szalai, 2006 .

Genetic influence on thrombotic risk markers in the elderly – a Danish twin study

K. Christensen, J. Hjelmborg, J. Hjelmborg, 2006, Journal of thrombosis and haemostasis : JTH.

Factor VII polymorphisms in populations with different risks of cardiovascular disease.

P. de Knijff, P. Knijff, J. Jespersen, 1997, Arteriosclerosis, thrombosis, and vascular biology.

9 Genetic variation in PCAF, a key mediator in epigenetics, is associated with reduced vascular morbidity and mortality

R. J. Winter, J. Jukema, S. Trompet, 2013 .

CLEC4M and STXBP5 gene variations contribute to von Willebrand factor level variation in von Willebrand disease

A. Isaacs, C. Duijn, J. Eikenboom, 2015, Journal of thrombosis and haemostasis : JTH.

Association between fibrinogen and fibrinogen γ' and atherosclerotic plaque morphology and composition in symptomatic carotid artery stenosis: Plaque-At-RISK study.

J. Hendrikse, P. Koudstaal, A. Lugt, 2019, Thrombosis research.

Effect of genetic background and diet on plasma fibrinogen in mice. Possible relation with susceptibility to atherosclerosis.

J. Verheijen, F. Rezaee, M. D. de Maat, 2000, Atherosclerosis.

Genetic determinants of von Willebrand factor plasma levels and the risk of stroke: the Rotterdam Study

A. Hofman, J. Witteman, P. Koudstaal, 2012, Journal of thrombosis and haemostasis : JTH.

Lower levels of ADAMTS13 are associated with cardiovascular disease in young patients.

J. Deckers, D. Poldermans, F. Leebeek, 2009, Atherosclerosis.

Clinically relevant differences between assays for von Willebrand factor activity

J. Eikenboom, F. Leebeek, W. V. van Heerde, 2018, Journal of thrombosis and haemostasis : JTH.

Low ADAMTS‐13 activity and the risk of coronary heart disease – a prospective cohort study: the Rotterdam Study

O. Franco, A. Hofman, M. Kavousi, 2016, Journal of thrombosis and haemostasis : JTH.

Decrease of hemostatic cardiovascular risk factors by aggressive vs. conventional atorvastatin treatment in patients with Type 2 diabetes mellitus

C. Kluft, A. Meinders, H. Princen, 2003, Journal of thrombosis and haemostasis : JTH.

Biological variation in inflammatory and hemostatic markers

F. Leebeek, C. Kluft, P. Meijer, 2009, Journal of thrombosis and haemostasis : JTH.